BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30
• 31

• Deals

  WuXi AppTec Denies Issuing Press Release Regarding Great Basin Scientific

  December 23, 2015

   · 

  1 min read
• Drug Development

  Seattle Genetics And Bristol-Myers Squibb Announce Initiation Of Phase 1/2 Clinical Trial Of ADCETRIS® (Brentuximab Vedotin) In Combination With Opdivo (Nivolumab) In Relapsed Or Refractory Non-Hodgkin Lymphoma

  December 23, 2015

   · 

  20 min read
• Drug Development

  Helix Biopharma Initiates Enrollment For Fifteenth Cohort In Polish Phase I/II Clinical Study Of Its Lung Cancer Drug Candidate L-DOS47

  December 23, 2015

   · 

  5 min read
• Business

  Lightlake Announces Collaboration With NIDA And The Perelman School Of Medicine At The University of Pennsylvania

  December 23, 2015

   · 

  6 min read
• BioMidwest

  EnteroMedics Announces 1-for-15 Reverse Split

  December 23, 2015

   · 

  5 min read
• Genetown

  Merrimack Announces Private Placement Of $175 Million of Senior Secured Notes

  December 23, 2015

   · 

  4 min read
• Drug Development

  Select Biosciences Announces Dosing Of First Patient In Phase 1b Clinical Trial Of SEL-212, Designed To Be The First Non-Immunogenic Biologic Treatment For Gout

  December 23, 2015

   · 

  6 min read
• BioCapital

  NW Bio Announces A Registered Direct Offering Of $12.6 Million

  December 23, 2015

   · 

  4 min read
• Pharm Country

  Interpace Diagnostics Group Begins Trading On NASDAQ

  December 23, 2015

   · 

  3 min read
• Pharm Country

  WHO To Review Merck & Co.’s Investigational Ebola Vaccine For Emergency Use Assessment And Listing

  December 23, 2015

   · 

  4 min read